The glioma immune landscape: A double-edged sword for treatment regimens
S Mahajan, MHH Schmidt, U Schumann - Cancers, 2023 - mdpi.com
Simple Summary Glioblastoma (GBM) is the most severe and aggressive form of primary
brain tumor with a poor prognosis. Currently, the treatment for GBM treatment involves …
brain tumor with a poor prognosis. Currently, the treatment for GBM treatment involves …
Chromatin remodelling molecule ARID1A determines metastatic heterogeneity in triple-negative breast cancer by competitively binding to YAP
Y Wang, X Chen, X Qiao, Y Xie, D Guo, B Li, J Cao… - Cancers, 2023 - mdpi.com
Simple Summary Heterogeneity is a prominent characteristic of triple-negative breast
cancer, and it remains the predominant cause of treatment failure. ARID1A, a key subunit of …
cancer, and it remains the predominant cause of treatment failure. ARID1A, a key subunit of …
Oncogenic PIK3CA recruits myeloid‐derived suppressor cells to shape the immunosuppressive tumour microenvironment in luminal breast cancer through the 5 …
X Li, G Chen, F Wang, X Guo, R Zhang… - Clinical and …, 2023 - Wiley Online Library
Background: Oncogenic PIK3CA mutations (PIK3CAmut) frequently occur in a higher
proportion in luminal breast cancer (LBC), especially in refractory advanced cases, and are …
proportion in luminal breast cancer (LBC), especially in refractory advanced cases, and are …
[PDF][PDF] The Glioma Immune Landscape: A Double-Edged Sword for Treatment Regimens. Cancers 2023, 15, 2024
S Mahajan, MHH Schmidt, U Schumann - 2023 - brainlife.org
Immune cells constitute a major part of the tumor microenvironment, thereby playing an
important role in regulating tumor development. They interact with tumor cells, resulting in …
important role in regulating tumor development. They interact with tumor cells, resulting in …